new data findings/day
patient tests analyzed
Access over 40 genomic, clinical and pharmaceutical databases updated weekly by hundreds of expert curators.
Enrich your NGS analysis and interpretations with cutting-edge bioinformatics software solutions trusted by thousands worldwide.
Make improvements in life possible by partnering with one bioinformatics software provider empowering you from Sample to Insight.
Have you reserved your in-person or virtual spot at the European Human Genetics Conference (ESHG) he...
Do you ever struggle to formulate hypotheses based on your experimental expression data? You may be ...
The latest COSMIC Actionability release is here with a focus on the ERBB2 gene. Before we delve into...
You need biomedical relationships knowledge for innovative data- and analytics-driven drug discovery...
More mutations, better annotations, confident classifications HGMD Professional 2022.1 is now av...
Scale your exome workflow with Dr. Atil Bisgin at ESHG 2022
Three easy ways to process your expression data to gain biological insights
How to track the progress of ERBB2-targeted therapies from early case studies to market with COSMIC Actionability
Accelerate your data science-driven drug discovery: Announcing QIAGEN Biomedical Knowledge Base
New Content Release: HGMD Professional 2022.1
Targeted NGS panels and optimized analysis and interpretation bioinformatics software tools.
Discovery Bioinformatics Services is a reliable and convenient way to extend your in-house resources with expertise and perfectly tailored bioinformatics software and services that ensure high-quality results.
Enabling pharma companies to develop biomarker diagnostics and targeted therapies using real-world insights from oncology patient genomic data.
Helping clinical testing laboratories leverage the benefits of automation and expert support to improve test turnaround times, enhance clinical reporting capabilities and scale for future growth.
Join us at an event or attend a webinar to learn how our products, solutions and services are empowering customers around the world to unlock valuable molecular insights.
Çukurova University in Adana, Turkey, analyzes the ancient origins of rare genetic diseases
Scientists at the University of Washington develop new Ebola model and find clues to genetics of host resistance
Mount Sinai identifies a novel prognostic biomarker associated with treatement response in ovarian cancer patients